This pattern was observed in multiple patients as evidenced by increased expression of FN in high malignant NSCLC patients (Fig. 1B; n = 10), indicating a potential association between FN and NSCLC progression. This evidence concerns the gene FN1 and non-small cell lung carcinoma.